FHTX stock

Foghorn Therapeutics Inc (FHTX) financials · rev $30.9M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Foghorn Therapeutics Inc (FHTX) rev $30.9M.

Cached annual income statement
LineFY2025FY2024
Revenue$30.9M$22.6M
Operating Income-$86.4M-$102.7M
Net Income-$74.3M-$86.6M
EPS (Diluted)-$1.18-$1.58
Cached annual balance sheet
LineFY2025FY2024
Total Assets$198.1M$284.0M
Current Assets$163.2M$249.6M
Cash & Equivalents$80.9M$55.5M
Total Liabilities$306.6M$329.5M
Current Liabilities$59.7M$67.0M
Shareholders' Equity-$108.5M-$45.5M
Retained Earnings-$632.5M-$558.2M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$86.1M-$100.4M
CapEx$50.0K$906.0K
Investing Cash Flow$112.0M-$29.9M
Financing Cash Flow$1.02M$105.4M
Free Cash Flow-$86.1M-$101.3M
These statements as JSON? API free 100/day

FAQ

What is FHTX P/E and revenue?

Foghorn Therapeutics Inc (FHTX) rev $30.9M.

What is FHTX revenue?

Foghorn Therapeutics Inc last cached revenue is $30.9M (FY2025).

Is FHTX profitable?

Foghorn Therapeutics Inc last cached net income is -$74.3M (FY2025).

What are FHTX total assets?

Foghorn Therapeutics Inc last cached total assets are $198.1M (FY2025).

What is FHTX free cash flow?

Foghorn Therapeutics Inc last cached free cash flow is -$86.1M (FY2025).

Not investment advice. Cached statements, not a live tape.